Prospective randomized open label blinded endpoint (PROBE) trial of high versus low dose mesalazine for prevention of relapse in patients with UC in remission

✍ Scribed by Deventer, Sander J.H.; Hommes, Daniel W.; Roskam-Mul, Miranda D.M.; Dekker, Willem; Gasthuis, Kennemer; Wetzels, A; Nelis, Frits; Stronkhorst, Arnold; Engels, Leopold G.; Snel, Pleun; Schook, G; Meuwissen, Stefan G.M.; Tytgat, Guido N.J.

• Book ID: 124111307
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 181 KB
• Volume: 120
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(08)82250-0